Skip to main content

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

NDC 58602-807 · Aurohealth LLC

Generic nameFexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
Dosage formTABLET, FILM COATED, EXTENDED RELEASE
RouteORAL
Active ingredient(s)FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE
Strength60; 120 mg/1; mg/1
Pharmacologic classAdrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

58602-807-67 — 2 BLISTER PACK in 1 CARTON (58602-807-67) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

58602-807-83 — 1 BLISTER PACK in 1 CARTON (58602-807-83) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

58602-807-84 — 3 BLISTER PACK in 1 CARTON (58602-807-84) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

56062-614 — guaifenesin, pseudoephedrine hydrochloride, 56062-847 — fexofenadine hydrochloride, 57344-292 — Fexofenadine Hydrochloride, 57483-230 — Fexofenadine Hydrochloride, 57483-240 — Fexofenadine Hydrochloride, 58407-625 — CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE, 58602-426 — Fexofenadine Hydrochloride Oral, 58602-703 — Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-803 — Ibuprofen and Pseudoephedrine HCl, 58602-804 — Pseudoephedrine HCl, 58602-816 — Naproxen Sodium and Pseudoephedrine Hydrochloride, 58602-832 — Naproxen Sodium and Pseudoephedrine Hydrochloride, 58602-833 — Guaifenesin and Pseudoephedrine HCl, 58602-834 — Guaifenesin and Pseudoephedrine HCl, 58602-839 — Ibuprofen and Pseudoephedrine Hydrochloride, 58602-844 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-876 — Fexofenadine Hydrochloride, 58602-877 — Fexofenadine Hydrochloride, 58602-878 — Fexofenadine Hydrochloride, 58602-884 — pseudoephedrine hydrochloride, +483 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels